Title : Sirolimus for patients with connective tissue disease-related refractory thrombocytopenia: a single-arm, open-label clinical trial.

Pub. Date : 2021 Jun 18

PMID : 33200217






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The present study investigated the efficacy and safety of sirolimus in refractory CTD-TP patients. Sirolimus CTD Homo sapiens
2 CONCLUSION: Sirolimus is an effective and safe treatment option for refractory CTD-TP patients. Sirolimus CTD Homo sapiens